The central formulation question for sh-Octapeptide-4 is not simply whether it can be added to a cosmetic base. The useful question is whether the selected commercial grade remains correctly identified, sufficiently stable, compatible, and analytically trackable in the intended finished product throughout manufacturing and shelf life.
This article uses the publicly stated formulation guidance from the Green Stone Swiss sh-Octapeptide-4 product page as a starting point. The page states that its advice is for reference only and that formulators should follow their own production guidance. Controlled TDS instructions and finished-formula testing still govern scale-up decisions.
Confirm the material before designing the process
Begin with the commercial grade you intend to buy. The product page describes:
- INCI: sh-Octapeptide-4
- Common name on page: MOTS-c, Mitochondrial-derived Peptide
- Appearance: white to off-white powder
- Purity: ≥99%
- Solubility: water soluble
- Origin: China
Request:
- the approved INCI declaration and complete composition information needed for your market;
- peptide assay or purity definitions and units that support the ≥99% claim;
- confirmation that the shipment is the neat powder grade described on the page;
- the current TDS, SDS, specification, and representative COA;
- the supplier’s supported storage and processing instructions;
- the analytical method used to track the material or relevant markers.
Also compare the page common name MOTS-c with the INCI and any CosIng-linked description before locking claim language. If the mapping is unclear, confirm it in an inquiry together with the current TDS and COA.
Without this information, two formulas using the same nominal percentage may not contain the same amount or form of the ingredient.
Start from the published process window, then verify it
Product-page formulation suggestions for this grade (public starting points; confirm by inquiry before scale-up):
| Parameter | Product-page guidance |
|---|---|
| Suggested use level | 0.5%–2% |
| Addition stage | Cool-down phase |
| Temperature | Below 45°C (113°F) |
| pH stability | Typical cosmetic range 4.0–7.0 |
| Avoid | High temperatures and strong oxidizing agents |
| Chassis fit | Water-soluble; suitable for essences, hydrogels, and emulsions |
| Example concepts | Revitalizing serums, cellular-repair creams, overnight recovery masks, anti-fatigue eye creams |
Treat these values as supplier-stated starting points. Confirm them against the current TDS, then validate in your formula:
- Does the peptide remain within the agreed assay or purity acceptance criterion at the formula’s target pH?
- What changes occur if manufacturing temporarily leaves the 4.0–7.0 window?
- Does any step above 45°C reduce recovery or change appearance?
- Do oxidants or other high-risk excipients create instability?
- Is the selected use level justified by stability, sensory, cost, and claim needs—not only by the page range?
Translate development goals into testable questions
CosIng associates SH-OCTAPEPTIDE-4 with anti-seborrheic, antioxidant, chelating, reducing, and skin-protecting functions. The product page positions the grade for cellular anti-aging and revitalizing concepts. Neither source replaces finished-product substantiation.
Convert the brief into test questions:
- What formula role is intended: revitalizing serum, eye cream, mask, emulsion, or another chassis?
- Which finished-product claims, if any, will depend on this ingredient versus the full formula?
- What analytical or sensory endpoints will decide pass or fail during development?
- What packaging and shelf-life conditions must the peptide survive?
- Which manufacturing steps create the highest heat, pH, or oxidation exposure?
The product page also suggests exploring combinations with Coenzyme Q10, resveratrol, or niacinamide for cellular-energy concept work. Treat those as optional screening ideas, not proven compatibility or synergy claims. Test each combination in the actual system before using it in a formula brief.
Build a staged compatibility screen
Avoid building a compatibility list from marketing copy alone. Test the actual sh-Octapeptide-4 grade with the actual formula.
1. Base compatibility
Dissolve or disperse the powder in the intended water phase or base before adding the full active system. Record appearance, odor, color, pH, clarity or turbidity, and any precipitation over time.
2. High-risk component groups
Prioritize:
- strong oxidizing agents and other redox-active ingredients;
- strong acids or bases and temporary pH excursions outside 4.0–7.0;
- metal-containing materials and chelating systems;
- electrolytes;
- surfactants and emulsifiers;
- botanical extracts with variable composition;
- preservatives, fragrances, and colorants;
- other peptides or protein hydrolysates that complicate assay interpretation.
3. Process simulation
Simulate cool-down addition below 45°C, then stress the expected commercial hold times, shear, and recirculation. Sample at critical points.
4. Packaging interaction
Evaluate the filled formula in the intended primary pack. Consider light, oxygen, headspace, closure integrity, and product-contact materials.
Design a stability plan that matches the decision
Include, as justified by the product:
- physical endpoints: appearance, odor, viscosity, separation, pH;
- chemical endpoints: peptide assay or agreed marker method;
- microbiological endpoints according to the preservative system and product type;
- packaging endpoints: weight loss, leakage, interaction, and closure performance;
- use-condition checks if the product is dispensed repeatedly.
Agree acceptance criteria before the study starts. If the analytical method cannot distinguish the peptide from interfering formula components, resolve the method issue before drawing stability conclusions.
Separate raw-material stability from finished-product stability
Page-stated powder stability guidance does not automatically define finished-product shelf life. Document:
- raw-material storage and retest or expiry conditions from the current SDS/TDS;
- any laboratory stock-solution preparation method and its holding time;
- finished-product stability conditions and acceptance criteria;
- whether a failed result is caused by the peptide, the base, the process, or the package.
Common failure modes to investigate early
- Was the correct powder grade and assay basis used?
- Was the peptide fully dissolved before emulsification or filling?
- Did a heat step exceed 45°C or leave the stated pH window?
- Did an oxidant or other high-risk system create an interaction?
- Is the analytical method recovering the peptide consistently from the matrix?
- Is the issue visible only after packaging or transport simulation?
A practical next step
Lock the identity of the commercial grade and the test methods you will use to track it. Then run a focused compatibility and process screen around the page-stated 0.5%–2% use level, pH 4.0–7.0 window, and cool-down addition below 45°C.
Request the current TDS and a representative sample of sh-Octapeptide-4 through an inquiry, then run compatibility and stability testing in your chassis. Use the supplier reply to confirm processing conditions before pilot manufacturing. The product page notes free samples with buyer-paid shipping and MOQ examples of 1 g / 10 g / 1 kg; ask the sales contact to reconfirm current terms.
